nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Congestive cardiomyopathy—Docetaxel—head and neck cancer	0.078	0.078	CcSEcCtD
Gemifloxacin—Platelet count decreased—Hydroxyurea—head and neck cancer	0.0265	0.0265	CcSEcCtD
Gemifloxacin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.015	0.015	CcSEcCtD
Gemifloxacin—Blood urea increased—Hydroxyurea—head and neck cancer	0.0149	0.0149	CcSEcCtD
Gemifloxacin—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.0125	0.0125	CcSEcCtD
Gemifloxacin—Renal failure acute—Hydroxyurea—head and neck cancer	0.0124	0.0124	CcSEcCtD
Gemifloxacin—Haemoglobin decreased—Docetaxel—head and neck cancer	0.0119	0.0119	CcSEcCtD
Gemifloxacin—Face oedema—Hydroxyurea—head and neck cancer	0.011	0.011	CcSEcCtD
Gemifloxacin—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.0107	0.0107	CcSEcCtD
Gemifloxacin—Breast disorder—Hydroxyurea—head and neck cancer	0.0103	0.0103	CcSEcCtD
Gemifloxacin—Pancreatitis—Hydroxyurea—head and neck cancer	0.00969	0.00969	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00947	0.00947	CcSEcCtD
Gemifloxacin—Photosensitivity—Fluorouracil—head and neck cancer	0.00938	0.00938	CcSEcCtD
Gemifloxacin—Agranulocytosis—Vinblastine—head and neck cancer	0.00902	0.00902	CcSEcCtD
Gemifloxacin—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.009	0.009	CcSEcCtD
Gemifloxacin—Infestation NOS—Hydroxyurea—head and neck cancer	0.00882	0.00882	CcSEcCtD
Gemifloxacin—Infestation—Hydroxyurea—head and neck cancer	0.00882	0.00882	CcSEcCtD
Gemifloxacin—Haemoglobin—Vinblastine—head and neck cancer	0.00872	0.00872	CcSEcCtD
Gemifloxacin—Haemorrhage—Vinblastine—head and neck cancer	0.00868	0.00868	CcSEcCtD
Gemifloxacin—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00866	0.00866	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00864	0.00864	CcSEcCtD
Gemifloxacin—Pharyngitis—Vinblastine—head and neck cancer	0.00861	0.00861	CcSEcCtD
Gemifloxacin—Stomatitis—Hydroxyurea—head and neck cancer	0.00859	0.00859	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00834	0.00834	CcSEcCtD
Gemifloxacin—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00819	0.00819	CcSEcCtD
Gemifloxacin—Haemoglobin—Hydroxyurea—head and neck cancer	0.00795	0.00795	CcSEcCtD
Gemifloxacin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00791	0.00791	CcSEcCtD
Gemifloxacin—Skin exfoliation—Docetaxel—head and neck cancer	0.00782	0.00782	CcSEcCtD
Gemifloxacin—Candida infection—Docetaxel—head and neck cancer	0.00782	0.00782	CcSEcCtD
Gemifloxacin—Angiopathy—Hydroxyurea—head and neck cancer	0.00718	0.00718	CcSEcCtD
Gemifloxacin—Dysphagia—Fluorouracil—head and neck cancer	0.00712	0.00712	CcSEcCtD
Gemifloxacin—Eosinophilia—Fluorouracil—head and neck cancer	0.00705	0.00705	CcSEcCtD
Gemifloxacin—Anaemia—Vinblastine—head and neck cancer	0.00698	0.00698	CcSEcCtD
Gemifloxacin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00683	0.00683	CcSEcCtD
Gemifloxacin—Vertigo—Vinblastine—head and neck cancer	0.00679	0.00679	CcSEcCtD
Gemifloxacin—Leukopenia—Vinblastine—head and neck cancer	0.00676	0.00676	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0065	0.0065	CcSEcCtD
Gemifloxacin—Pneumonia—Fluorouracil—head and neck cancer	0.00638	0.00638	CcSEcCtD
Gemifloxacin—Anaemia—Hydroxyurea—head and neck cancer	0.00637	0.00637	CcSEcCtD
Gemifloxacin—Hot flush—Docetaxel—head and neck cancer	0.00635	0.00635	CcSEcCtD
Gemifloxacin—Infestation—Fluorouracil—head and neck cancer	0.00635	0.00635	CcSEcCtD
Gemifloxacin—Infestation NOS—Fluorouracil—head and neck cancer	0.00635	0.00635	CcSEcCtD
Gemifloxacin—Menopausal symptoms—Docetaxel—head and neck cancer	0.0063	0.0063	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00622	0.00622	CcSEcCtD
Gemifloxacin—Stomatitis—Fluorouracil—head and neck cancer	0.00618	0.00618	CcSEcCtD
Gemifloxacin—Leukopenia—Hydroxyurea—head and neck cancer	0.00617	0.00617	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00604	0.00604	CcSEcCtD
Gemifloxacin—Hyponatraemia—Docetaxel—head and neck cancer	0.00597	0.00597	CcSEcCtD
Gemifloxacin—Agranulocytosis—Fluorouracil—head and neck cancer	0.00592	0.00592	CcSEcCtD
Gemifloxacin—Anorexia—Vinblastine—head and neck cancer	0.00588	0.00588	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00582	0.00582	CcSEcCtD
Gemifloxacin—Haemoglobin—Fluorouracil—head and neck cancer	0.00572	0.00572	CcSEcCtD
Gemifloxacin—Haemorrhage—Fluorouracil—head and neck cancer	0.0057	0.0057	CcSEcCtD
Gemifloxacin—Pharyngitis—Fluorouracil—head and neck cancer	0.00565	0.00565	CcSEcCtD
Gemifloxacin—Oedema—Hydroxyurea—head and neck cancer	0.00562	0.00562	CcSEcCtD
Gemifloxacin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00551	0.00551	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0055	0.0055	CcSEcCtD
Gemifloxacin—Skin disorder—Hydroxyurea—head and neck cancer	0.00546	0.00546	CcSEcCtD
Gemifloxacin—Breast disorder—Docetaxel—head and neck cancer	0.00537	0.00537	CcSEcCtD
Gemifloxacin—Anorexia—Hydroxyurea—head and neck cancer	0.00536	0.00536	CcSEcCtD
Gemifloxacin—Decreased appetite—Vinblastine—head and neck cancer	0.00536	0.00536	CcSEcCtD
Gemifloxacin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00535	0.00535	CcSEcCtD
Gemifloxacin—Pain—Vinblastine—head and neck cancer	0.00527	0.00527	CcSEcCtD
Gemifloxacin—Constipation—Vinblastine—head and neck cancer	0.00527	0.00527	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00524	0.00524	CcSEcCtD
Gemifloxacin—Dysphagia—Docetaxel—head and neck cancer	0.00514	0.00514	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00504	0.00504	CcSEcCtD
Gemifloxacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00501	0.00501	CcSEcCtD
Gemifloxacin—Somnolence—Hydroxyurea—head and neck cancer	0.005	0.005	CcSEcCtD
Gemifloxacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00495	0.00495	CcSEcCtD
Gemifloxacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00489	0.00489	CcSEcCtD
Gemifloxacin—Abdominal pain—Vinblastine—head and neck cancer	0.00487	0.00487	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00485	0.00485	CcSEcCtD
Gemifloxacin—Fatigue—Hydroxyurea—head and neck cancer	0.00485	0.00485	CcSEcCtD
Gemifloxacin—Pain—Hydroxyurea—head and neck cancer	0.00481	0.00481	CcSEcCtD
Gemifloxacin—Constipation—Hydroxyurea—head and neck cancer	0.00481	0.00481	CcSEcCtD
Gemifloxacin—Pneumonia—Docetaxel—head and neck cancer	0.00461	0.00461	CcSEcCtD
Gemifloxacin—Anaemia—Fluorouracil—head and neck cancer	0.00458	0.00458	CcSEcCtD
Gemifloxacin—Infestation NOS—Docetaxel—head and neck cancer	0.00458	0.00458	CcSEcCtD
Gemifloxacin—Infestation—Docetaxel—head and neck cancer	0.00458	0.00458	CcSEcCtD
Gemifloxacin—Renal failure—Docetaxel—head and neck cancer	0.0045	0.0045	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00449	0.00449	CcSEcCtD
Gemifloxacin—Stomatitis—Docetaxel—head and neck cancer	0.00446	0.00446	CcSEcCtD
Gemifloxacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.00444	0.00444	CcSEcCtD
Gemifloxacin—Leukopenia—Fluorouracil—head and neck cancer	0.00444	0.00444	CcSEcCtD
Gemifloxacin—Asthenia—Vinblastine—head and neck cancer	0.00442	0.00442	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00433	0.00433	CcSEcCtD
Gemifloxacin—Agranulocytosis—Docetaxel—head and neck cancer	0.00427	0.00427	CcSEcCtD
Gemifloxacin—Myalgia—Fluorouracil—head and neck cancer	0.00422	0.00422	CcSEcCtD
Gemifloxacin—Diarrhoea—Vinblastine—head and neck cancer	0.00422	0.00422	CcSEcCtD
Gemifloxacin—Haemoglobin—Docetaxel—head and neck cancer	0.00413	0.00413	CcSEcCtD
Gemifloxacin—Haemorrhage—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Gemifloxacin—Pharyngitis—Docetaxel—head and neck cancer	0.00408	0.00408	CcSEcCtD
Gemifloxacin—Dizziness—Vinblastine—head and neck cancer	0.00408	0.00408	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00406	0.00406	CcSEcCtD
Gemifloxacin—Oedema peripheral—Docetaxel—head and neck cancer	0.00405	0.00405	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00405	0.00405	CcSEcCtD
Gemifloxacin—Oedema—Fluorouracil—head and neck cancer	0.00405	0.00405	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00404	0.00404	CcSEcCtD
Gemifloxacin—Asthenia—Hydroxyurea—head and neck cancer	0.00403	0.00403	CcSEcCtD
Gemifloxacin—Urethral disorder—Docetaxel—head and neck cancer	0.00403	0.00403	CcSEcCtD
Gemifloxacin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00397	0.00397	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00396	0.00396	CcSEcCtD
Gemifloxacin—Visual impairment—Docetaxel—head and neck cancer	0.00396	0.00396	CcSEcCtD
Gemifloxacin—Tachycardia—Fluorouracil—head and neck cancer	0.00395	0.00395	CcSEcCtD
Gemifloxacin—Vomiting—Vinblastine—head and neck cancer	0.00392	0.00392	CcSEcCtD
Gemifloxacin—Erythema multiforme—Docetaxel—head and neck cancer	0.00389	0.00389	CcSEcCtD
Gemifloxacin—Headache—Vinblastine—head and neck cancer	0.00386	0.00386	CcSEcCtD
Gemifloxacin—Anorexia—Fluorouracil—head and neck cancer	0.00386	0.00386	CcSEcCtD
Gemifloxacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00385	0.00385	CcSEcCtD
Gemifloxacin—Eye disorder—Docetaxel—head and neck cancer	0.00384	0.00384	CcSEcCtD
Gemifloxacin—Flushing—Docetaxel—head and neck cancer	0.00382	0.00382	CcSEcCtD
Gemifloxacin—Cardiac disorder—Docetaxel—head and neck cancer	0.00382	0.00382	CcSEcCtD
Gemifloxacin—Angiopathy—Docetaxel—head and neck cancer	0.00373	0.00373	CcSEcCtD
Gemifloxacin—Dizziness—Hydroxyurea—head and neck cancer	0.00372	0.00372	CcSEcCtD
Gemifloxacin—Immune system disorder—Docetaxel—head and neck cancer	0.00371	0.00371	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Docetaxel—head and neck cancer	0.00371	0.00371	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00369	0.00369	CcSEcCtD
Gemifloxacin—Nausea—Vinblastine—head and neck cancer	0.00366	0.00366	CcSEcCtD
Gemifloxacin—Insomnia—Fluorouracil—head and neck cancer	0.00366	0.00366	CcSEcCtD
Gemifloxacin—Dyspnoea—Fluorouracil—head and neck cancer	0.00361	0.00361	CcSEcCtD
Gemifloxacin—Mental disorder—Docetaxel—head and neck cancer	0.0036	0.0036	CcSEcCtD
Gemifloxacin—Somnolence—Fluorouracil—head and neck cancer	0.0036	0.0036	CcSEcCtD
Gemifloxacin—Vomiting—Hydroxyurea—head and neck cancer	0.00357	0.00357	CcSEcCtD
Gemifloxacin—Dyspepsia—Fluorouracil—head and neck cancer	0.00356	0.00356	CcSEcCtD
Gemifloxacin—Rash—Hydroxyurea—head and neck cancer	0.00354	0.00354	CcSEcCtD
Gemifloxacin—Dermatitis—Hydroxyurea—head and neck cancer	0.00354	0.00354	CcSEcCtD
Gemifloxacin—Headache—Hydroxyurea—head and neck cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Decreased appetite—Fluorouracil—head and neck cancer	0.00352	0.00352	CcSEcCtD
Gemifloxacin—Dysgeusia—Docetaxel—head and neck cancer	0.0035	0.0035	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00349	0.00349	CcSEcCtD
Gemifloxacin—Back pain—Docetaxel—head and neck cancer	0.00346	0.00346	CcSEcCtD
Gemifloxacin—Pain—Fluorouracil—head and neck cancer	0.00346	0.00346	CcSEcCtD
Gemifloxacin—Muscle spasms—Docetaxel—head and neck cancer	0.00344	0.00344	CcSEcCtD
Gemifloxacin—Nausea—Hydroxyurea—head and neck cancer	0.00334	0.00334	CcSEcCtD
Gemifloxacin—Anaemia—Docetaxel—head and neck cancer	0.00331	0.00331	CcSEcCtD
Gemifloxacin—Urticaria—Fluorouracil—head and neck cancer	0.00321	0.00321	CcSEcCtD
Gemifloxacin—Syncope—Docetaxel—head and neck cancer	0.00321	0.00321	CcSEcCtD
Gemifloxacin—Leukopenia—Docetaxel—head and neck cancer	0.0032	0.0032	CcSEcCtD
Gemifloxacin—Body temperature increased—Fluorouracil—head and neck cancer	0.0032	0.0032	CcSEcCtD
Gemifloxacin—Palpitations—Docetaxel—head and neck cancer	0.00316	0.00316	CcSEcCtD
Gemifloxacin—Loss of consciousness—Docetaxel—head and neck cancer	0.00315	0.00315	CcSEcCtD
Gemifloxacin—Myalgia—Docetaxel—head and neck cancer	0.00305	0.00305	CcSEcCtD
Gemifloxacin—Arthralgia—Docetaxel—head and neck cancer	0.00305	0.00305	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00303	0.00303	CcSEcCtD
Gemifloxacin—Dry mouth—Docetaxel—head and neck cancer	0.00298	0.00298	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Oedema—Docetaxel—head and neck cancer	0.00292	0.00292	CcSEcCtD
Gemifloxacin—Shock—Docetaxel—head and neck cancer	0.00287	0.00287	CcSEcCtD
Gemifloxacin—Nervous system disorder—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Pruritus—Fluorouracil—head and neck cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Gemifloxacin—Tachycardia—Docetaxel—head and neck cancer	0.00285	0.00285	CcSEcCtD
Gemifloxacin—Skin disorder—Docetaxel—head and neck cancer	0.00284	0.00284	CcSEcCtD
Gemifloxacin—Anorexia—Docetaxel—head and neck cancer	0.00278	0.00278	CcSEcCtD
Gemifloxacin—Diarrhoea—Fluorouracil—head and neck cancer	0.00277	0.00277	CcSEcCtD
Gemifloxacin—Dizziness—Fluorouracil—head and neck cancer	0.00268	0.00268	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00266	0.00266	CcSEcCtD
Gemifloxacin—Insomnia—Docetaxel—head and neck cancer	0.00264	0.00264	CcSEcCtD
Gemifloxacin—Dyspnoea—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Somnolence—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Gemifloxacin—Vomiting—Fluorouracil—head and neck cancer	0.00257	0.00257	CcSEcCtD
Gemifloxacin—Dyspepsia—Docetaxel—head and neck cancer	0.00257	0.00257	CcSEcCtD
Gemifloxacin—Rash—Fluorouracil—head and neck cancer	0.00255	0.00255	CcSEcCtD
Gemifloxacin—Dermatitis—Fluorouracil—head and neck cancer	0.00255	0.00255	CcSEcCtD
Gemifloxacin—Decreased appetite—Docetaxel—head and neck cancer	0.00254	0.00254	CcSEcCtD
Gemifloxacin—Headache—Fluorouracil—head and neck cancer	0.00254	0.00254	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00252	0.00252	CcSEcCtD
Gemifloxacin—Fatigue—Docetaxel—head and neck cancer	0.00252	0.00252	CcSEcCtD
Gemifloxacin—Constipation—Docetaxel—head and neck cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Pain—Docetaxel—head and neck cancer	0.0025	0.0025	CcSEcCtD
Gemifloxacin—Nausea—Fluorouracil—head and neck cancer	0.0024	0.0024	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00239	0.00239	CcSEcCtD
Gemifloxacin—Abdominal pain—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Body temperature increased—Docetaxel—head and neck cancer	0.00231	0.00231	CcSEcCtD
Gemifloxacin—Asthenia—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Gemifloxacin—Pruritus—Docetaxel—head and neck cancer	0.00207	0.00207	CcSEcCtD
Gemifloxacin—Diarrhoea—Docetaxel—head and neck cancer	0.002	0.002	CcSEcCtD
Gemifloxacin—Dizziness—Docetaxel—head and neck cancer	0.00193	0.00193	CcSEcCtD
Gemifloxacin—Vomiting—Docetaxel—head and neck cancer	0.00186	0.00186	CcSEcCtD
Gemifloxacin—Rash—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Dermatitis—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Gemifloxacin—Headache—Docetaxel—head and neck cancer	0.00183	0.00183	CcSEcCtD
Gemifloxacin—Nausea—Docetaxel—head and neck cancer	0.00173	0.00173	CcSEcCtD
